QSC RESEARCH GRADE
≥99% HPLC PurityMS ConfirmedJanoshik COA5-Region Domestic Shipping
What is Semaglutide 30mg?
Semaglutide is a GLP-1R agonist with 94% sequence homology to native GLP-1, acylated for extended half-life (~7 days). The 30mg/vial format provides a high-dose configuration for research protocols requiring elevated single-dose concentrations or reduced reconstitution frequency. GLP-1R activation suppresses appetite via hypothalamic pathways, delays gastric emptying, and stimulates glucose-dependent insulin secretion. SUSTAIN and STEP program Phase 3 data: 15-17% mean weight reduction. The 30mg format is suited for sustained high-dose protocols, stock preparation for high-throughput research, and studies at concentrations above standard 10-20mg formats.
Research Applications
High-Dose GLP-1R Research
30mg/vial concentrates research stock — suited for extended DIO mouse studies, concentrated in vitro experiments, or stock preparation for multi-animal research.
Dose-Escalation Ceiling Studies
Enables research at the upper range of semaglutide dose-response curves — ceiling effect and receptor saturation studies.
GLP-1R Pharmacology
Same mechanism as lower-dose formats — GLP-1R agonism, appetite suppression, insulin secretion, gastric emptying. High-dose format for maximal receptor occupancy research.
Quick Specs
| Product | Semaglutide 30mg × 10 Vials (300mg total) |
| Mechanism | GLP-1R agonist |
| Format | Lyophilised powder, 10-vial kit |
| Purity | ≥99% HPLC, MS confirmed |
| Half-Life | ~7 days (acylated) |
| Storage | −20°C lyophilised; 4°C reconstituted |
